Elon Musk's brief but tumultuous stint in the Trump Administration as head of the cost-cutting DOGE agency ended, leaving behind a controversial legacy of sweeping cuts and layoffs amidst unmet savings goals, legal challenges, and clashes with officials.
Elon Musk and multiple senior officials are departing Trump's Department of Government Efficiency (DOGE) as their 130-day tenures as special government employees expire, signaling potential shifts in the administration's aggressive cost-cutting efforts that have sparked legal battles.
The whirlwind saga of Sam Altman's firing and rehiring as OpenAI's CEO within five days is set to hit the big screen as a comedic movie titled 'Artificial', with Andrew Garfield potentially starring as Altman and Luca Guadagnino in talks to direct.
The FDA's new AI tool for reviewing medical devices, CDRH-GPT, is struggling with basic tasks like uploading documents and accessing recent studies, raising concerns about rushing AI adoption before it's ready to handle complex regulatory work accurately and safely.
Paradromics, a neurotech startup rivaling Elon Musk's Neuralink, successfully implanted and removed its brain-computer interface device during human surgery, marking a major milestone as it prepares for broader clinical trials to help people with severe motor impairments like paralysis.
Researchers speculate that DeepSeek, a Chinese AI lab, may have trained its latest model using outputs from Google's Gemini AI, raising concerns about potential misuse of proprietary data and highlighting the challenges of preventing distillation in the rapidly evolving AI landscape.
Luca Guadagnino is set to direct 'Artificial,' a comedic drama about artificial intelligence, for Amazon MGM Studios, reuniting with the studio after his recent films 'After the Hunt' and 'Challengers.'
Elon Musk's AI startup, xAI, is reportedly launching a $300 million tender offer that values the company at $113 billion, allowing staff to sell shares while raising funds for future growth amidst challenges with Musk's other ventures.
Neurotech startup Paradromics has achieved a major milestone by successfully implanting its brain-computer interface in a human for the first time, paving the way for a clinical trial later this year to study the long-term safety and use of its technology.
Meta plans to automate up to 90% of risk assessments for new features and updates on its platforms like Facebook and Instagram, replacing human evaluators with AI systems that will determine potential privacy violations, harm to minors, and spread of misinformation, raising concerns about oversight and unintended consequences.